The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Liadov K.V.
Lechebno-reabilitatsionnyĭ tsentr Minzdravsotsrazvitiia Rossiĭskoĭ Federatsii, Moskva
Kaprin A.D.
FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii
Rerberg A.G.
P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia, Moscow, Russia
Kozyrin I.A.
Klinika khirurgii i onkologii Lechebno-reabilitatsionnogo tsentra Minzdrava RF, Moskva
Lyadov V.K.
Medical and Rehabilitation Center under the Ministry of Health of Russian Federation, Moscow, Russia
Maiorov K.V.
Limited Liability Company «BEBIG», Moscow, Russia
Kaprin D.A.
Department of Surgery, Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, Moscow, Russia
Moroz O.V.
Faculty of fundamental medicine, Moscow State University
Cherednichenko D.V.
Joint Stock Company «RusAtom Healthcare», Moscow, Russia
Dobreva I.Yu.
Joint Stock Company «RusAtom Healthcare», Moscow, Russia
Polushkin V.G.
Rossiĭskiĭ natsional'nyĭ issledovatel'skiĭ meditsinskiĭ universitet imeni N.I. Pirogova;
Gorodskaia klinicheskaia bol'nitsa #31, Moskva
Khodovsky A.A.
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia
Therapy for inoperable hepatocellular carcinoma with selective transarterial radioembolization with yttrium-90 microspheres
Journal: P.A. Herzen Journal of Oncology. 2018;7(3): 55‑60
Views: 3400
Downloaded: 136
To cite this article:
Liadov KV, Kaprin AD, Rerberg AG, et al. . Therapy for inoperable hepatocellular carcinoma with selective transarterial radioembolization with yttrium-90 microspheres. P.A. Herzen Journal of Oncology.
2018;7(3):55‑60. (In Russ.)
https://doi.org/10.17116/onkolog20187355
Hepatocellular carcinoma is generally diagnosed at a late stage, which makes surgical treatment difficult. According to the Barcelona Clinic Liver Cancer (BCLC) staging system, patients with inoperable tumors can undergo transarterial chemoembolization or palliative therapy with sorafenib, their response rate does not exceed 30%. At the same time, the results of transarterial radioembolization (TARE) using yttrium-90-containing microspheres demonstrate an optimistic picture. In this paper, the authors systematize from expert positions the current data from the literature on the use of TARE to treat liver cancer in clinical practice and formulate prospects for using the technique in the Russian Federation. Based on the literature data, the authors demonstrate the superiority of TARE over sorafenib therapy and the results that are comparable with chemoembolization.
Authors:
Liadov K.V.
Lechebno-reabilitatsionnyĭ tsentr Minzdravsotsrazvitiia Rossiĭskoĭ Federatsii, Moskva
Kaprin A.D.
FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii
Rerberg A.G.
P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia, Moscow, Russia
Kozyrin I.A.
Klinika khirurgii i onkologii Lechebno-reabilitatsionnogo tsentra Minzdrava RF, Moskva
Lyadov V.K.
Medical and Rehabilitation Center under the Ministry of Health of Russian Federation, Moscow, Russia
Maiorov K.V.
Limited Liability Company «BEBIG», Moscow, Russia
Kaprin D.A.
Department of Surgery, Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, Moscow, Russia
Moroz O.V.
Faculty of fundamental medicine, Moscow State University
Cherednichenko D.V.
Joint Stock Company «RusAtom Healthcare», Moscow, Russia
Dobreva I.Yu.
Joint Stock Company «RusAtom Healthcare», Moscow, Russia
Polushkin V.G.
Rossiĭskiĭ natsional'nyĭ issledovatel'skiĭ meditsinskiĭ universitet imeni N.I. Pirogova;
Gorodskaia klinicheskaia bol'nitsa #31, Moskva
Khodovsky A.A.
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.